{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T21:52:21Z","timestamp":1783029141699,"version":"3.54.6"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>Neuroendocrine transdifferentiation refers to the progressive transformation of a nonneuroendocrine tumor to the one showing evidence of neuroendocrine differentiation on morphological and immunohistochemical grounds. Although this phenomenon has been well-documented in certain malignancies, particularly prostatic adenocarcinoma after androgen deprivation, cases of neuroendocrine transdifferentiation in melanomas are exceptionally rare. Herein, we report a case of a conventional superficial spreading melanoma occurring on the skin of the leg in a young male which showed progressive neuroendocrine transdifferentiation as it progressed through 2 in-transit metastases and a nodal metastatic deposit over a 4-year period. The tumor retained the <jats:italic toggle=\"yes\">BRAF<\/jats:italic> V600E mutation throughout the disease process, and disease control was achieved through dual BRAF inhibition therapy. The possibility of melanoma masquerading as a high-grade neuroendocrine malignancy when investigating tumors of unknown primary should be kept in the mind of clinicians and histopathologist alike as a potential diagnostic pitfall, thus helping avoid misdiagnosis and guide appropriate treatment strategies.<\/jats:p>","DOI":"10.1097\/dad.0000000000002377","type":"journal-article","created":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T22:01:58Z","timestamp":1678917718000},"page":"264-268","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Neuroendocrine Transdifferentiation in Cutaneous Melanoma: A Case Report and Review of the Literature"],"prefix":"10.1097","volume":"45","author":[{"given":"David","family":"Pisani","sequence":"first","affiliation":[{"name":"Cellular Pathology, Pathology Department, Mater Dei Hospital, Msida, Malta;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Micallef","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Mater Dei Hospital, Msida, Malta; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanesse","family":"Scerri","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Pathology and Genetics, Pathology Department, Mater Dei Hospital, Msida, Malta."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Betts","sequence":"additional","affiliation":[{"name":"Cellular Pathology, Pathology Department, Mater Dei Hospital, Msida, Malta;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Degaetano","sequence":"additional","affiliation":[{"name":"Cellular Pathology, Pathology Department, Mater Dei Hospital, Msida, Malta;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7501-0842","authenticated-orcid":false,"given":"Shawn","family":"Baldacchino","sequence":"additional","affiliation":[{"name":"Cellular Pathology, Pathology Department, Mater Dei Hospital, Msida, Malta;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,2,17]]},"reference":[{"key":"R1-20250616","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13000-021-01135-x","article-title":"Prognostic significance of the aberrant expression of neuroendocrine markers in melanomas","volume":"16","author":"Wu","year":"2021","journal-title":"Diagn Pathol."},{"key":"R2-20250616","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s12032-021-01473-2","article-title":"De novo neuroendocrine transdifferentiation in primary prostate cancer-a phenotype associated with advanced clinico-pathologic features and aggressive outcome","volume":"38","author":"Abdulfatah","year":"2021","journal-title":"Med Oncol."},{"key":"R3-20250616","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12022-022-09708-2","article-title":"Overview of the 2022 WHO classification of neuroendocrine neoplasms","volume":"33","author":"Rindi","year":"2022","journal-title":"Endocr Pathol."},{"key":"R4-20250616","doi-asserted-by":"crossref","first-page":"763992","DOI":"10.3389\/fonc.2021.763992","article-title":"Malignant melanoma with neuroendocrine differentiation: a case report and literature review","volume":"11","author":"Cham","year":"2021","journal-title":"Front Oncol."},{"key":"R5-20250616","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13256-020-02367-z","article-title":"Metastatic malignant melanoma with neuroendocrine differentiation: a case report and review of the literature","volume":"14","author":"Juhlin","year":"2020","journal-title":"J Med Case Rep."},{"key":"R6-20250616","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1007\/s12105-022-01437-6","article-title":"Base of tongue metastasis of cutaneous malignant melanoma with rhabdoid and neuroendocrine features: report of a rare case and review of the literature","volume":"16","author":"Tzanavaris","year":"2022","journal-title":"Head Neck Pathol."},{"key":"R7-20250616","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2559.2007.02823.x","article-title":"Divergent differentiation in malignant melanomas: a review","volume":"52","author":"Banerjee","year":"2008","journal-title":"Histopathology"},{"key":"R8-20250616","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1365-2559.2005.02240.x","article-title":"Malignant melanoma with neuroendocrine differentiation: clinical, histological, immunohistochemical and ultrastructural features of three cases","volume":"47","author":"Eyden","year":"2005","journal-title":"Histopathology"},{"key":"R9-20250616","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/1066896915573568","article-title":"Anal melanoma with neuroendocrine differentiation: report of a case","volume":"23","author":"Ilardi","year":"2015","journal-title":"Int J Surg Pathol."},{"key":"R10-20250616","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s43046-020-00051-3","article-title":"Primary urethral small cell melanoma with neuroendocrine differentiation: a case report","volume":"32","author":"Nakra","year":"2020","journal-title":"J Egypt Natl Canc Inst."},{"key":"R11-20250616","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/01913123.2020.1740367","article-title":"Sinonasal amelanotic melanoma with neuroendocrine differentiation: a diagnostic conundrum","volume":"44","author":"Kaur","year":"2020","journal-title":"Ultrastruct Pathol."},{"key":"R12-20250616","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/PAI.0b013e3181ee8dcb","article-title":"Immunophenotypic heterogeneity of primary sinonasal melanoma with aberrant expression of neuroendocrine markers and calponin","volume":"19","author":"Lee","year":"2011","journal-title":"Appl Immunohistochem Mol Morphol."},{"key":"R13-20250616","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2559.2004.01784.x","article-title":"Aberrant neurofilament protein and synaptophysin expression in malignant melanoma of the nasal cavity","volume":"44","author":"Coli","year":"2004","journal-title":"Histopathology"},{"key":"R14-20250616","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2324-8599.1000109","article-title":"Primary chorioidal melanoma with divergent neuroendocrine differentiation","volume":"2","author":"Pelayes","year":"2013","journal-title":"Int J Ophthalmic Pathol."},{"key":"R15-20250616","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mpdhp.2015.12.003","article-title":"Primary, vasocentric uveal melanoma with pseudorosettes and neuroendocrine differentiation","volume":"22","author":"Mulay","year":"2016","journal-title":"Diagn Histopathol."},{"issue":"8","key":"R16-20250616","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/modpathol.2015.62","article-title":"Aberrant intermediate filament and synaptophysin expression is a frequent event in malignant melanoma: an immunohistochemical study of 73 cases","volume":"28","author":"Romano","year":"2015","journal-title":"Mod Pathol."}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000002377","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T18:04:30Z","timestamp":1750097070000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000002377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,17]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000002377","relation":{},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,17]]},"assertion":[{"value":"2022-10-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}